Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Sep 15, 2024; 16(9): 3781-3797
Published online Sep 15, 2024. doi: 10.4251/wjgo.v16.i9.3781
Published online Sep 15, 2024. doi: 10.4251/wjgo.v16.i9.3781
Cancer type | Eph receptor | Aberrant function | Role of Eph receptor |
Colorectal cancer | EphA1 | Overexpressed in early stages; low expression in later stages | Tumour suppressive |
EphA2 | Overexpressed in early stages; low expression in later stages | Tumour suppressive | |
EphA3 | Low expression | Tumour suppressive | |
EphA4 | Overexpressed | Tumour promoting | |
EphA7 | Low expression | Tumour suppressive | |
EphB2 | Overexpressed in early stages; low expression in later stages | Tumour suppressive | |
EphB3 | Overexpressed in early stages; low expression in later stages | Tumour suppressive | |
EphB4 | Overexpressed | Tumour promoting | |
EphB6 | Low expression | Tumour suppressive |
- Citation: Zhang YK, Shi R, Meng RY, Lin SL, Zheng M. Erythropoietin-induced hepatocyte receptor A2 regulates effect of pyroptosis on gastrointestinal colorectal cancer occurrence and metastasis resistance. World J Gastrointest Oncol 2024; 16(9): 3781-3797
- URL: https://www.wjgnet.com/1948-5204/full/v16/i9/3781.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i9.3781